Viewpoint

Our latest infographic brings together an extensive collection of fascinating facts and statistics about the production of natural active molecules and compares traditional field-based production and new bioproduction methods.

Current challenges
Active natural molecules (secondary metabolites)

The challenges ahead 
 API production is facing rising costs alongside unpredictable pressures such as climate change, the need to use land for food production and geopolitical uncertainty. To help you find out more about these challenges and other issues, we’ve collated these thought-provoking articles. 

The Effects of Climate Change on Medicinal and Aromatic Plants 

Published by the American Botanical Council, this article looks into the impact of climate change on medicinal plants. Studies have demonstrated that increases in temperature could impact their medicinal activity which has implications for drug production.

https://www.herbalgram.org/resources/herbalgram/issues/81/table-of-contents/article3379/

Managing Land Carrying Capacity: Key to Achieving Sustainable Production Systems for Food Security 

March 27 2022 

How will the planet sustainably feed nine billion people in 2050 and beyond? Published by MDPI, this article looks at the environmental challenges ahead such as increasing food production while reducing the use of fertilizers. Non-food crops may encounter challenges as the demand for agricultural land dedicated to food production continues to rise. 

https://www.mdpi.com/2073-445X/11/4/484

7 Ways to Increase Pharmaceutical Sustainability

September 05 2023 

While it’s crucial that the pharmaceutical industry continues to supply medications globally, it also needs to safeguard the planet’s health. Published by Pharma News Intelligence this article looks at ways to increase pharmaceutical sustainability, such as choosing technologies that can help preserve biodiversity and natural ecosystems. 

https://pharmanewsintel.com/features/7-ways-to-increase-pharmaceutical-sustainability#:~:text=Sustainable%20Sourcing,alternatives%20to%20non-renewable%20resources

‘Right shoring’ API production in Europe 

22 March 2023  

By 2020, only 25% of API production for generic drugs took place in Europe. When Covid-19 hit, EU countries experienced drug shortages as the global supply chain stuttered. Published by Pharmaceutical Technology, this article looks at the current trend in the pharmaceutical industry to shift back to regional suppliers. 

https://www.pharmaceutical-technology.com/features/right-shoring-api-production-in-europe-2/

Effects of Geopolitical Strain on Global Pharmaceutical Supply Chain Design and Drug Shortages

August 14 2023 

Uncertainty in the pharmaceutical industry’s supply chain will increasingly impact drug availability in the decades ahead. Published by Cornell University, this article looks at the causes, such as geopolitical instability. 

https://arxiv.org/abs/2308.07434

Geopolitical tensions expected to increase to 2050 

August 11 2023  

How will geopolitical instability impact the pharmaceutical industry in future decades? This article in Engineering News explores the risks. One major concern is that climate change will increase disputes between countries over natural resources. 

https://www.engineeringnews.co.za/article/geopolitical-tensions-expected-to-increase-to-2050-2023-08-11

Plant cell culture deep dive: As cracks emerge in botanical supply chains, ‘It’s a huge space to watch’ 

May 5 2023   

For companies like Samabriva at the cutting-edge of plant cell culture these are exciting times. According to this article published by AgFunder News, the sustainability, stability and consistency of growing plants in a bioreactor are increasingly compelling for the pharmaceutical industry

https://agfundernews.com/plant-cell-culture-ready-for-prime-time-in-food-and-nutraceuticals

What the experts have to say

We interviewed experts to understand what they believe will happen to API production in the coming years.

From global to local – what’s needed to transform API supply chains

21 November 2023  

Over the last 20 years, the supply chain for over-the-counter and generic active pharmaceutical ingredients (API) has changed beyond all recognition. Where Europe once dominated, Asia has completely reversed the API production dynamic. However, if production is to return to Europe cost inequalities between the US and EU and Asia need to be addressed. Adopting new technologies that offer economically viable, local alternatives will be crucial.

https://samabriva.com/wp-content/uploads/2023/11/Risks-to-the-API-supply-chain_v0.5_clean_compressed.pdf

Navigating risks: examining the threats to API production amidst climate change challenges

16 January 2024  

Experts are increasingly worried about the impact of climate change on medicinal plants. Increases in temperature could affect crop and metabolite yields which has implications for the pharmaceutical industry. In this article we look at some of the potential threats, such as the risk of medicinal activity reducing in these crops due to fluctuating temperatures.

https://samabriva.com/wp-content/uploads/2024/01/Navigating-risks_compressed.pdf